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Lymphangioleiomyomatosis (LAM), a rare multisystem disease affecting mainly young women, is char-
acterized by an abnormal proliferation of smooth muscle-like cells in the lungs. We report a case of
endometriosis with chronic pelvic pain due to pelvic LAM. A 41-year-old gravida 1, para 1 woman had
been experiencing intermittent left pelvic pain for several years. She also complained of dyspnea on
effort 2 years previously, and was diagnosed with pulmonary LAM. Abdominal magnetic resonance
imaging showed a right ovarian endometriotic cyst and a left pelvic mass. She was referred to our
hospital for the treatment of pelvic pain; she underwent laparoscopic cystectomy of the right ovarian
endometriotic cyst. Her left pelvic cyst was found in the retroperitoneal space, and biopsy conﬁrmed the
diagnosis of LAM. Therefore, we suggest that LAM localized in the pelvis should be considered when a
patient with pulmonary LAM presents with pelvic pain or abdominal distention.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Lymphangioleiomyomatosis (LAM) is very rare disease that
mainly affects women of reproductive age. The pathological feature
of LAM is an abnormal proliferation of smooth muscle-like cells
(LAM cells) mainly in the wall of airways, venules, and lymphatic
vessels in the lungs. The proliferation of these cells causes gradual
obstruction of small airways, frequently resulting in respiratory
failure and death. Patients with pulmonary LAM have mainly res-
piratory symptoms such as dyspnea on effort, chest pain, cough,
and sputum with or without blood. However, LAM sometimes af-
fects extrapulmonary lesions such as retroperitoneal lymphatic
tumors (lymphangioleiomyomas) and renal angiomyolipomas,
causing abdominal distention, abdominal pain, lymphedema of the
lower extremities, and hematuria. Here we report a difﬁcult-to-s of interest relevant to this
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for Gynecologic Endoscopy and Minim
nses/by-nc-nd/4.0/).diagnose case of endometriosis in a patient who complained of
chronic pelvic pain due to pelvic LAM.Case report
A 41-year-old gravida 1, para 1 woman was referred to our
hospital for the treatment of pelvic pain. She had presented with
complaints of dyspnea on effort 2 years previously, and had
received a diagnosis of pulmonary LAM and bilateral renal angio-
myolipomas from her physician. She also had been experiencing
left pelvic pain for several years, which gradually worsened. The
visual analogue scale score of her pelvic pain was 6e10/10. Mag-
netic resonance imaging revealed an endometriotic cyst in her right
ovary and a left ovarian cyst or retroperitoneal cyst in her left pelvic
cavity. Her previous gynecologist thought that surgery was needed;
however, surgery was not possible because of the patient's low
respiratory function. Her respiratory function test revealed severe
pulmonary obstructive dysfunction (percentage vital capacity (%
VC), 125%; percent predicted forced expiratory volume in one sec-
ond (FEV1.0%), 29.1%). Chest radiography showed diffuse reticular
shadows in both lungs, and her breathlessness was categorized as
Grade 2 in the HugheJones classiﬁcation. She also had multipleally Invasive Therapy. Published by Elsevier Taiwan LLC. This is an open access article under
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Transvaginal ultrasonography revealed that the right ovarian cyst
had a mosaic pattern and was enlarged to 5 cm in diameter, and a
hypoechoic cystic lesion that had a small solid portion on the inside
in her left pelvis. Although the cancer antigen 125 level increased to
85 IU/mL, other tumor makers were within the normal range in her
blood test. On magnetic resonance imaging the right adnexal cyst
was 6 cm in diameter with high-signal intensity on both T1- and
T2-weighted imaging, and was diagnosed as an endometriotic cyst.
The cystic mass in the left pelvis was 5 cm in diameter with low-
signal intensity on T1- and high-signal intensity on T2-weighted
imaging. Moreover, in the caudal side of the left adnexa, there
was an area of high-signal intensity on T1-weighted imaging after
gadolinium enhancement.
Considering all these ﬁndings, we tentatively diagnosed the left
pelvic mass as LAM although we could not completely eliminate a
possibility of left malignant ovarian tumor. We performed laparo-
scopic right salpingo-oophorectomy (RSO) using the usual
approach. We could not ﬁnd any obvious endometriotic lesion
except for right ovarian endometriotic cyst in her pelvis. After RSO,
we conﬁrmed that the left ovary was normal and the cystic lesion
was located in the left retroperitoneal space (Figures 1A and 1B).
We separated the cyst from the left peritoneum, and ﬁnally opened
the cyst. We conﬁrmed the presence of ash-gray ﬂuid content and
mural nodulewithin the cyst, and took samples as much as possible
for pathological analysis (Figures 1C and 1D). We could not
completely remove the cyst wall from the retroperitoneal space
because it was ﬁrmly attached to the surrounding tissue. The
operation timewas 2 hours 21 minutes and the total blood loss was
30 mL. The patient's postoperative course was uneventful, and she
was discharged from our hospital 4 days after the operation
without any complications.
The cytology ﬁndings showed many spindle-shaped LAM cells
in the ﬂuid from the left retroperitoneal cyst (Figure 2A). Hema-
toxylineeosin staining showed spindle-shaped cells withoutFigure 1. Laparoscopic operation ﬁndings. Pelvic lymphangioleiomyomatosis located in the
(open arrow). Cystic mass before (A, B, C) and after (D) aspirating its content.atypia, and the proliferation of interstitial tissue (Figure 2B). In the
immunohistochemical studies, the tumorwas positive for anti-Org-
D2, anti-HMB45, anti-aSMA, anti-estrogen receptor, and anti-
progesterone receptor antibodies (Figures 2Ce2G). Finally, left
retroperitoneal LAM complicated with right ovarian endometriotic
cyst was diagnosed.
The patient received outpatient care for 6 months after surgery
without any additional therapy. Her visual analogue scale score
decreased to 0e1/10 after surgery. We suggested left salpingo-
oophorectomy to the patient because LAM might subside after
bilateral oophorectomy, but she did not accept it because she
worried about postmenopausal symptoms.
Discussion
LAM is very raremultisystem disease that affects mainly women
of childbearing age. Its usual presentation is dyspnea, pneumo-
thorax, chylous pleural effusion, and hemoptysis. The prognosis is
poor because of progressive obstructive respiratory dysfunction.
The estimated prevalence rate of LAM in Japan is 1.2e2.3/1,000,000
persons.1
LAM is categorized into two groups: (1) LAM in conjunctionwith
tuberous sclerosis complex (TSC); and (2) LAM without evidence of
other diseases (sporadic LAM). In 1994 the genetic background of
LAM was discovered to be somatic or germline mutations of the
tumor suppressor genes TSC1 and TSC2.2 It is thought that LAM
patients with TSC have one germline mutation (predominantly in
TSC2) and one acquired mutation, and that sporadic LAM develops
in the presence of two acquired mutations in TSC genes (again
predominantly in TSC2) in somatic cells. In the lungs, multiple
cystic lesions form because of the proliferation of LAM cells that
have TSC gene abnormality. LAM forms not only pulmonary lesions
but also extrapulmonary lesions. The common extrapulmonary
abnormalities are angiomyolipomas, abdominal effusion contain-
ing LAM cells, and enlargement of the mediastinal andleft retroperitoneal space (closed arrow) and the removed right endometriotic cyst wall
Figure 2. Pathological ﬁndings (400). (A) Cytology: lymphangioleiomyomatosis cells in the cyst. (B) Hematoxylineeosin staining. (C) Org-D2 staining. (D) Anti-HMB45 antibody.
(E) Anti-aSMA antibody. (F) Anti-estrogen receptor antibody. (G) Antiprogesterone receptor antibody.
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pelvis.3 Evidence has shown that LAMmay be inﬂuenced by female
sex hormones. Some reports mentioned that LAMworsened during
pregnancy and that bilateral oophorectomy improved respiratory
function.4,5
Pathological studies are important for the diagnosis of LAM.
LAM cells can be classiﬁed into two types: smaller spindle-shaped
cells and larger epithelioid cells with abundant cytoplasm.6
Immunohistochemical analysis is also important. We performed
immunohistochemical staining of LAM cells with anti-HMB45, anti-
aSMA, anti-estrogen receptor, and antiprogesterone receptor anti-
bodies. The positive rate of these staining tests is 80% for anti-HMB45 antibody, 98% for anti-aSMA antibody, 53% for anti-
estrogen receptor antibody, and 68% for antiprogesterone recep-
tor antibody, respectively.
Recently, sirolimus (rapamycin) has drawn attention as a
possible therapeutic agent for LAM. LAM is associated with an
inappropriate activation of mammalian target of rapamycin
(mTOR) signaling, and sirolimus inactivates mTOR, consequently
inhibiting cell proliferation.7
Pelvic LAM before the appearance of respiratory symptoms was
reported previously.8 Preoperative diagnosis is thought to be more
difﬁcult in these cases. In most of the patients with extrapulmonary
lesion, the diagnosis of respiratory lesionwasmadewithin 1 year or
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et al10 reported a case of LAM complicated with a retroperitoneal
tumor composed of LAM cells. The patient did not complain of
pelvic pain, which suggests that pelvic LAM may not always cause
lower abdominal pain.
In our case it was difﬁcult to determine whether the cause of
pelvic pain was caused by endometriosis or retroperitoneal LAM
before surgery.11,12 The pain of this patient was left lower abdomen
ipsilateral to the LAM lesion, therefore, we speculated that LAM in
the retroperitoneal lesion swelled out and irritated the peritoneum,
which should cause her chronic pelvic pain.
Taking all the ﬁndings together, we concluded that her chronic
pelvic pain was due to left retroperitoneal LAM, not endometriosis.
Pelvic LAM should be considered as a differential diagnosis when
patients present with pelvic pain coexistent with a pulmonary LAM
lesion. We suggest that LAM localized in the pelvis should be
considered when a patient with pulmonary LAM presents with
pelvic pain or abdominal distention. Laparoscopic lymph node bi-
opsy is a valuable tool in solving such a diagnostic dilemma.
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